STOCK-BASED COMPENSATION | 13 – STOCK-BASED COMPENSATION 2015 Equity Incentive Plan Stock Options The following table summarizes the stock option activity for the three months ended March 31, 2023: Weighted Weighted Number Average Average of Exercise Fair Options Price Value Outstanding as of January 1, 2023 415,227 $ 7.91 $ 2.78 Granted — — — Exercised (14,091) 7.89 2.69 Forfeited — — — Outstanding as of March 31, 2023 401,136 $ 7.91 $ 2.79 Exercisable as of March 31, 2023 364,826 $ 7.71 $ 2.63 The following table summarizes certain information about the options outstanding as of March 31, 2023: Options Outstanding and Unvested, Options Outstanding and Exercisable, March 31, 2023 March 31, 2023 Weighted Weighted Weighted Average Weighted Average Weighted Average Exercise Price of Average Remaining Average Remaining Outstanding Number of Exercise Contractual Number of Exercise Contractual Options Options Price Life Options Price Life $ 7.91 36,310 $ 9.91 3.90 364,826 $ 7.71 3.00 As of March 31, 2023 and December 31, 2022, a total of 401,136 and 415,227 stock options were outstanding, respectively. The unamortized stock-based compensation balance of $47 as of March 31, 2023 is expected to be expensed $39 and $8 during the remainder of 2023 and during the year ending December 31, 2024, respectively. F or the three months ended March 31, 2023 and 2022, the Company recognized amortization expense of the fair value of its stock options, which is included in General and administrative expenses, as follows: For the Three Months Ended March 31, 2023 2022 General and administrative expenses $ 42 $ 113 Restricted Stock Units The Company has issued restricted stock units (“RSUs”) under the 2015 Plan to certain members of the Board of Directors and certain executives and employees of the Company, which represent the right to receive a share of common stock, or in the sole discretion of the Company’s Compensation Committee, the value of a share of common stock on the date that the RSU vests. As of March 31, 2023 and December 31, 2022, shares of the Company’s common stock were outstanding in respect of the RSUs, respectively. Such shares will only be issued in respect of vested RSUs issued to directors when the director’s service with the Company as a director terminates. Such shares of common stock will only be issued to executives and employees when their RSUs vest under the terms of their grant agreements and the amended 2015 Plan. The RSUs that have been issued to certain members of the Board of Directors generally vest on the date of the annual shareholders meeting of the Company following the date of the grant. three anniversaries of the determined vesting date. The table below summarizes the Company’s unvested RSUs for the three months ended March 31, 2023: Weighted Number of Average Grant RSUs Date Price Outstanding as of January 1, 2023 641,972 $ 15.74 Granted 76,425 18.04 Vested (178,922) 13.04 Forfeited — — Outstanding as of March 31, 2023 539,475 $ 16.96 The total fair value of the RSUs that vested during the three months ended March 31, 2023 and 2022 was $3,369 and $2,655 , respectively. The total fair value is calculated as the number of shares vested during the period multiplied by the fair value on the vesting date. The following table summarizes certain information of the RSUs unvested and vested as of March 31, 2023: Unvested RSUs Vested RSUs March 31, 2023 March 31, 2023 Weighted Weighted Average Weighted Average Remaining Average Number of Grant Date Contractual Number of Grant Date RSUs Price Life RSUs Price 539,475 $ 16.96 3.54 250,675 $ 11.19 The Company is amortizing these grants over the applicable vesting periods, net of anticipated forfeitures. As of March 31, 2023, unrecognized compensation cost of For the three months ended March 31, 2023 and 2022, the Company recognized nonvested stock amortization expense for the RSUs, which is included in General and administrative expenses as follows: For the Three Months Ended March 31, 2023 2022 General and administrative expenses $ 1,517 $ 577 |